Health

Risk Management in the Pharmaceuticals and Life Sciences Industry

October 31, 2009

Global

October 31, 2009

Global
Our Editors

The Economist Intelligence Unit

_____________________

In August 2009, the Economist Intelligence Unit conducted a global survey of executives in the pharmaceutical and life sciences industry on how risk is managed in their organisations. The 65 responses were compared with those of a June 2009 global survey of 353 executives in a broad range of other industries. Of the pharmaceutical and life sciences respondents, nearly half (46%) are C-level executives and the remainder are other senior executives and managers. Sixty-eight percent represent companies with annual global revenues above US$500m. The survey focused on North America (65% of respondents), but had respondents from Europe, Asia-Pacific, the Middle East and Africa, and Latin America as well. The Economist Intelligence Unit executed the survey, conducted the analysis and wrote the report. The findings and views expressed in the report do not necessarily reflect the views of the sponsor.

Economist Impact is a part of the Economist Group.
Occasionally, we would like to keep you informed about our newly-released content, events, our best subscription offers, and other new product offerings from The Economist Group.

The Economist Group is a global organisation and operates a strict privacy policy around the world. Please see our privacy policy here.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week